Pictet Asset Management (UK)’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$110M Buy
660,113
+289,320
+78% +$46.9M 0.12% 217
2021
Q1
$67.4M Buy
370,793
+204,642
+123% +$47.5M 0.08% 271
2020
Q4
$33.2M Buy
166,151
+137,251
+475% +$27.9M 0.04% 387
2020
Q3
$6.34M Sell
28,900
-400
-1% -$84.7K 0.01% 667
2020
Q2
$5.59M Buy
29,300
+27,400
+1,442% +$4.8M 0.01% 651
2020
Q1
$295K Buy
+1,900
New +$221K ﹤0.01% 1026

Other funds holding TDOC

Pictet Asset Management (UK)'s TDOC Position: Q2 2021 in Review

Pictet Asset Management (UK) increased its Teladoc Health (TDOC) stake by 78% in Q2 2021, buying an estimated $46.9M and bringing the position to 660,113 shares worth $110M. The position accounts for 0.12% of the portfolio, ranked #217.

Pictet Asset Management (UK) first reported a position in TDOC in Q1 2020 and has held it in 6 quarters since. 829 funds tracked by Wall St. Rank hold TDOC as of Q2 2021.

  • Pictet Asset Management (UK) held 660,113 shares of Teladoc Health worth $110M as of Q2 2021.
  • Pictet Asset Management (UK) bought 289,320 Teladoc Health shares in Q2 2021, an estimated $46.9M.
  • Teladoc Health made up 0.12% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #217 holding.
  • Pictet Asset Management (UK) first reported a position in Teladoc Health in Q1 2020 and has held it in 6 quarters since.
  • 829 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.